Receptor dimerization--rationale for the design of bivalent ligands
Ao Zhang1, Zhili Liu, Ying Kan
1Modern Synthetic Organic Chemistry Laboratory, Shanghai Institute of Materia Medica, CAS, 555 Zuchongzhi Lu, Pudong, Shanghai, China 201203. aozhang@mail.shcnc.ac.cn
Current Topics in Medicinal Chemistry
|February 20, 2007
Summary
Receptor dimerization, including homodimers and heterodimers, is crucial for function but not fully understood. Understanding these receptor complexes offers new avenues for rational drug design.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Receptor dimerization, involving homodimers and heterodimers, is increasingly recognized for its functional importance.
- Despite evidence, the precise biology and pharmacology of receptor dimerization remain incompletely elucidated.
- Crystal structures of dimerized proteins offer valuable insights into these molecular interactions.
Purpose of the Study:
- To review the current understanding of receptor homodimerization and heterodimerization.
- To highlight the significance of dimerization in receptor characterization and drug discovery.
- To explore the potential of dimerization in developing novel therapeutic strategies.
Main Methods:
- Literature review of existing studies on receptor dimerization.
- Analysis of crystal structures of dimerized proteins and protein-ligand complexes.
- Synthesis of current knowledge on the biological and pharmacological implications of dimerization.
Main Results:
- Confirmation of the widespread existence and functional significance of receptor homodimers and heterodimers.
- Identification of gaps in knowledge regarding the detailed mechanisms of dimerization.
- Demonstration of how structural data aids in understanding dimerization processes.
Conclusions:
- Receptor dimerization represents a common and functionally critical phenomenon.
- Dimerization provides a novel paradigm for receptor classification beyond traditional methods.
- Targeting receptor dimerization offers promising opportunities for rational drug design and discovery.
Related Concept Videos
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
02:51Metal-Ligand Bonds
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:28Diversity of Antigen Receptors
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
01:19Complexation Equilibria: The Chelate Effect
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...